CD55 polyclonal, anti-human
€470.00
In stock
SKU
AC-AP73433
Background:
This protein recognizes C4b and C3b fragments that condense with cell-surface hydroxyl or amino groups when nascent C4b and C3b are locally generated during C4 and c3 activation. Interaction of daf with cell-associated C4b and C3b polypeptides interferes with their ability to catalyze the conversion of C2 and factor B to enzymatically active C2a and Bb and thereby prevents the formation of C4b2a and C3bBb, the amplification convertases of the complement cascade (PubMed:7525274). Inhibits complement activation by destabilizing and preventing the formation of C3 and C5 convertases, which prevents complement damage (PubMed:28657829).
Other Names:
CD55; CR; DAF; Complement decay-accelerating factor; CD55
Antigen Type: synthetic peptide
Antigen Type: CD55
Gene ID: 1604
Primary Accession: P08174
This protein recognizes C4b and C3b fragments that condense with cell-surface hydroxyl or amino groups when nascent C4b and C3b are locally generated during C4 and c3 activation. Interaction of daf with cell-associated C4b and C3b polypeptides interferes with their ability to catalyze the conversion of C2 and factor B to enzymatically active C2a and Bb and thereby prevents the formation of C4b2a and C3bBb, the amplification convertases of the complement cascade (PubMed:7525274). Inhibits complement activation by destabilizing and preventing the formation of C3 and C5 convertases, which prevents complement damage (PubMed:28657829).
Other Names:
CD55; CR; DAF; Complement decay-accelerating factor; CD55
Antigen Type: synthetic peptide
Antigen Type: CD55
Gene ID: 1604
Primary Accession: P08174
| Is Featured? | No |
|---|
Write Your Own Review